Related Experiment Video
Updated: Feb 2, 2026

Single-Cell Suspension Preparation from Nile Tilapia Intestine for Single-Cell Sequencing
Published on: February 10, 2023
Nile Tilapia Derived Antimicrobial Peptide TP4 Exerts Antineoplastic Activity Through Microtubule Disruption
Chen-Hung Ting1, Yi-Chung Liu2, Ping-Chiang Lyu3
1Marine Research Station, Institute of Cellular and Organismic Biology, Academia Sinica, Ilan 262, Taiwan. koichiting@gmail.com.
Abstract:
Some antimicrobial peptides (AMPs) exhibit anti-cancer activity, acting on cancer cells either by causing membrane lysis or via intracellular effects. While intracellular penetration of AMPs has been shown to cause cancer cell death, the mechanisms of toxicity remain largely unknown. Here we show that a tilapia-derived AMP, Tilapia piscidin (TP) 4, penetrates intracellularly and targets the microtubule network. A pull-down assay identified α-Tubulin as a major interaction partner for TP4, and molecular docking analysis suggested that Phe1, Ile16, and Arg23 on TP4 are required for the interaction. TP4 treatment in A549 cells was found to disrupt the microtubule network in cells, and mutation of the essential TP4 residues prevented microtubule depolymerization in vitro. Importantly, the TP4 mutants also showed decreased cytotoxicity in A549 cells, suggesting that microtubule disruption is a major mechanistic component of TP4-mediated death in lung carcinoma cells.
Insights
Tilapia piscidin 4 (TP4), an antimicrobial peptide, kills lung cancer cells by disrupting their internal microtubule network. This disruption is crucial for TP4
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Antimicrobial peptides (AMPs) show potential anti-cancer effects through membrane lysis or intracellular actions.
- Mechanisms of AMP-induced cancer cell death via intracellular effects are not fully understood.
Purpose of the Study:
- To investigate the intracellular mechanisms of toxicity of a tilapia-derived antimicrobial peptide, Tilapia piscidin (TP) 4, in lung carcinoma cells.
- To determine if TP4 targets the microtubule network and if this interaction contributes to its anti-cancer activity.
Main Methods:
- Pull-down assays to identify TP4 interaction partners.
- Molecular docking to analyze the binding interface between TP4 and its target.
- Treatment of A549 lung carcinoma cells with TP4 and its mutants.
- Microscopy to assess microtubule network integrity.
- In vitro microtubule depolymerization assays.
Main Results:
- TP4 was found to penetrate A549 cells and interact with α-Tubulin.
- Specific residues (Phe1, Ile16, Arg23) on TP4 are critical for α-Tubulin binding.
- TP4 treatment disrupted the microtubule network in A549 cells.
- Mutations in these key residues abolished microtubule depolymerization and reduced TP4's cytotoxicity.
Conclusions:
- TP4 targets and disrupts the microtubule network in lung carcinoma cells.
- Microtubule disruption is a key mechanism underlying TP4-induced cancer cell death.
- TP4 represents a potential therapeutic agent for lung cancer, with its anti-cancer activity linked to microtubule targeting.
Related Concept Videos
Microtubules
Microtubules
Microtubules have two structurally similar globular protein subunits: α and β tubulins. In the cytosol, the α and β tubulins form a heterodimer....
Peptide Bonds
Antimicrobial Effectiveness
Microtubule Instability
Microtubule Formation

